Fujifilm India Installs 125 AMULET Innovality Digital Mammography Machines Across India

New Delhi : FUJIFILM India, a leading pioneer in advancing healthcare imaging technologies, has achieved a significant milestone by deploying 125 AMULET Innovality digital mammography machines across India, marking a noteworthy advancement in the field of digital mammography. This achievement underscores the company’s commitment to enhancing the fight against breast cancer and expanding its installation base continually.

According to Globocan data from 2020, breast cancer constituted 13.5% (178,361 cases) of all cancer diagnoses and 10.6% (90,408 cases) of all cancer-related deaths in India. These statistics emphasize the critical importance of early breast cancer detection in improving survival rates.

As reported by IndiaEducationDiary.com, FUJIFILM India believes it has a societal obligation to raise awareness about early breast cancer detection and equip healthcare professionals with cutting-edge technologies to better serve the community. To further this mission, the ‘Together Against Breast Cancer’ conference was held in Goa from September 15th to 17th, 2023.

Koji Wada, Managing Director, FUJIFILM India said, “At FUJIFILM India, our unwavering commitment to women’s health is exemplified by the technologies we bring and the advocacy we do for early diagnosis. The installation of 125 AMULET Innovality digital mammography machines across India are a testament to our dedication to enhance healthcare infrastructure for the early detection of breast cancer. However, I strongly feel that 125 is just a milestone in this journey and we will be expanding our installation base with a very fast pace in the near future. Beyond our advancements in healthcare technology, our ‘Together Against Breast Cancer’ Conference is proudly celebrating its 3rd edition, reinforcing our commitment to raising awareness. We firmly believe that improving access to technology and increasing awareness are pivotal steps toward fostering a healthier India”.

Related Posts

  • Pharma
  • July 26, 2024
  • 128 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 125 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD